Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated
Rising incidences of Pediatric cancer has provoked medical organizations towards development and implementation of sophisticated treatment procedures, which is “Proton Radiotherapy”. The efficiency of proton therapy continues to add trust of Pediatric cancer patients globally. The course of action is known for successfully destructing tumor cells by damaging their DNA during a targeted deposition of high-energy radiation dosage onto the tumor.
Globally the Pediatric cancer cases are increasing rapidly at a great pace. Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. United States dominates the proton therapy centers in the world because of its huge investment in the development of therapy centers as well as its elongated history of proton therapy.
USA leads the Pediatric Proton Therapy Market globally
USA has the highest pediatric proton therapy market share but gradually it will lose its market share in future, due to stiff competition from Germany, France, United Kingdom and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these 36 cancer types approximately, 15 percent of market share is taken by Ependymoma cancerous tumor.
United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market
The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.
United Kingdom, France and Germany is driving the Europe Pediatric Proton Therapy Market
Growing number of cancer diagnosed pediatric patients in Europe will enforce the many countries in Europe to expand proton therapy centers because of the demand. Improvement in Technology is playing a very crucial role in driving pediatric proton therapy market in Europe. Germany leads the pediatric proton therapy market in Europe. In 2010, France had the maximum market share of Pediatric Proton Therapy. Other countries studied in the reports are Switzerland, Czech Republic, Sweden, and United Kingdom.
Japan & China along with South Korea drives the Proton Therapy Market in Asia
Pediatric Proton therapy technology has immense potential as it is evident from the increasing number of proton therapy centers across Asia. Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.
Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated is the 20th report published by Renub Research on Proton Therapy Market. This 330 page report with 287 figures and 7 Tables provides 10 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Cancer Type Markets in USA, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies - IBA, Varian Medical Systems, Mitsubishi and Hitachi.
KEY QUESTIONS ANSWERED IN THE REPORT?
1. IBA
2. Varian Medical Systems
3. Mitsubishi
4. Hitachi
Countries Pediatric Proton Therapy Market & Number of Patients studied in the Report
1. United States
2. United Kingdom
3. Switzerland
4. Germany
5. France
6. Sweden
7. Czech Republic
8. Japan
9. Korea
10. China
Globally the Pediatric cancer cases are increasing rapidly at a great pace. Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. United States dominates the proton therapy centers in the world because of its huge investment in the development of therapy centers as well as its elongated history of proton therapy.
USA leads the Pediatric Proton Therapy Market globally
USA has the highest pediatric proton therapy market share but gradually it will lose its market share in future, due to stiff competition from Germany, France, United Kingdom and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these 36 cancer types approximately, 15 percent of market share is taken by Ependymoma cancerous tumor.
United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market
The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.
United Kingdom, France and Germany is driving the Europe Pediatric Proton Therapy Market
Growing number of cancer diagnosed pediatric patients in Europe will enforce the many countries in Europe to expand proton therapy centers because of the demand. Improvement in Technology is playing a very crucial role in driving pediatric proton therapy market in Europe. Germany leads the pediatric proton therapy market in Europe. In 2010, France had the maximum market share of Pediatric Proton Therapy. Other countries studied in the reports are Switzerland, Czech Republic, Sweden, and United Kingdom.
Japan & China along with South Korea drives the Proton Therapy Market in Asia
Pediatric Proton therapy technology has immense potential as it is evident from the increasing number of proton therapy centers across Asia. Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.
Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated is the 20th report published by Renub Research on Proton Therapy Market. This 330 page report with 287 figures and 7 Tables provides 10 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Cancer Type Markets in USA, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies - IBA, Varian Medical Systems, Mitsubishi and Hitachi.
KEY QUESTIONS ANSWERED IN THE REPORT?
- What is the Global Pediatric Proton Therapy Market and its growth potential in Future?
- What is the Number of pediatric patients treated by Proton Beam Therapy worldwide?
- What are the reimbursement policies for Proton Therapy across the world?
- What is the Pediatric Proton Therapy Market in United States and Forecast?
- What is the Number of Pediatric Proton Therapy Patients by age group in United States and Forecast
- What is the Number of Pediatric Proton Therapy Patients by tumor type in United States and Forecast
- What is the Pediatric Proton Therapy Market size in Asia (Japan, China and South Korea) and its growth potential in future?
- What is the Number of Pediatric Proton Therapy patients treated in Asia (Japan, China and South Korea)?
- What is the Pediatric Proton Therapy Market in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
- What is the Number of Pediatric Proton Therapy Patients in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
- What Type of Technology is being used at Proton Therapy Centers?
1. IBA
2. Varian Medical Systems
3. Mitsubishi
4. Hitachi
Countries Pediatric Proton Therapy Market & Number of Patients studied in the Report
1. United States
2. United Kingdom
3. Switzerland
4. Germany
5. France
6. Sweden
7. Czech Republic
8. Japan
9. Korea
10. China
1 RESEARCH FINDINGS
2 GLOBAL PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)
2.1 Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
2.2 Pediatric Patients with Proton Therapy Potential Numbers & Forecast
3 GLOBAL PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
3.1 Pediatric Proton Therapy Market & Forecast
3.2 Pediatric Proton Therapy - Potential Market & Forecast
4 GLOBAL PEDIATRIC PROTON THERAPY MARKET SHARE & FORECAST
4.1 By Region (Asia, Europe, USA) – Global Pediatric Proton Therapy Market Share
4.2 By Countries – Global Pediatric Proton Therapy Market Share
5 UNITED STATES PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
5.1 United States Pediatric Proton Therapy Market & Forecast
5.2 United States Potential Pediatric Proton Therapy Market & Forecast
6 USA PEDIATRIC PROTON THERAPY MARKET BY AGE GROUP
6.1 By Age Group (<1) Year
6.2 By Age Group (1-4) Year
6.3 By Age Group (5-9) Year
6.4 By Age Group (10-14) Year
6.5 By Age Group (15-18) Year
7 USA PEDIATRIC PROTON THERAPY PATIENT NUMBER - ACTUAL AND POTENTIAL
7.1 USA Pediatric Patients Treated with Proton Therapy Numbers & Forecast
7.2 USA Pediatric Patients with Proton Therapy Potential Numbers & Forecast
8 USA PEDIATRIC PROTON THERAPY PATIENTS NUMBERS BY AGE GROUP
8.1 By Age (<1) Year
8.2 By Age (1- 4) Year
8.3 By Age (5- 9) Year
8.4 By Age (10-14) Year
8.5 By Age (15- 18) Year
9 TUMOR TYPES – USA PEDIATRICS PROTON THERAPY MARKET (2010 – 2021)
9.1 Glioma, Low Grade – Market & Forecast
9.2 Glioma, High Grade – Market & Forecast
9.3 Medulloblastoma – Market & Forecast
9.4 Ependymoma – Market & Forecast
9.5 ATRT – Market & Forecast
9.6 Germinoma, Pure – Market & Forecast
9.7 Germ Cell Tumor – Market & Forecast
9.8 Craniopharyngioma – Market & Forecast
9.9 PNET – Market & Forecast
9.1 Pineoblastoma – Market & Forecast
9.11 Chordoma/Chondrosarcoma – Market & Forecast
9.12 Meningioma – Market & Forecast
9.13 AVM – Market & Forecast
9.14 Adenoma – Market & Forecast
9.15 Choroid Plexus Carcinoma – Market & Forecast
9.16 Retinoblastoma – Market & Forecast
9.17 Osteosarcoma – Market & Forecast
9.18 Ewing Sarcoma – Market & Forecast
9.19 Rhabdomyosarcoma – Market & Forecast
9.2 Other Sarcoma, High Grade – Market & Forecast
9.21 Other Sarcoma, Low Grade – Market & Forecast
9.22 Teratoma – Market & Forecast
9.23 Neuroblastoma – Market & Forecast
9.24 Ganglioglioma – Market & Forecast
9.25 Wilm’s Tumor – Market & Forecast
9.26 Carcinoma (non-CPC) – Market & Forecast
9.27 Lymphoma, Hodgkin’s – Market & Forecast
9.28 Lymphoma, Non-hodgkin’s – Market & Forecast
9.29 Leukemia – Market & Forecast
9.3 Desmoid – Market & Forecast
9.31 Melanoma – Market & Forecast
9.32 Pineal Parenchymal Tumor – Market & Forecast
9.33 Esthesioneuroblastoma – Market & Forecast
9.34 Angiofibroma – Market & Forecast
9.35 Extrarenal Rhabdoid Tumor – Market & Forecast
9.36 Others – Market & Forecast
10 TUMOR TYPES USA PEDIATRICS PROTON THERAPY PATIENTS (2010 – 2021)
10.1 Glioma, Low Grade – Patient Numbers & Forecast
10.2 Glioma, High Grade - Patient Numbers & Forecast
10.3 Medulloblastoma - Patient Numbers & Forecast
10.4 Ependymoma - Patient Numbers & Forecast
10.5 ATRT - Patient Numbers & Forecast
10.6 Germinoma, pure - Patient Numbers & Forecast
10.7 Germ Cell Tumor - Patient Numbers & Forecast
10.8 Craniopharyngioma - Patient Numbers & Forecast
10.9 PNET - Patient Numbers & Forecast
10.1 Pineoblastoma - Patient Numbers & Forecast
10.11 Chordoma/Chondrosarcoma - Patient Numbers & Forecast
10.12 Meningioma - Patient Numbers & Forecast
10.13 AVM - Patient Numbers & Forecast
10.14 Adenoma - Patient Numbers & Forecast
10.15 Choroid Plexus Carcinoma - Patient Numbers & Forecast
10.16 Retinoblastoma - Patient Numbers & Forecast
10.17 Osteosarcoma - Patient Numbers & Forecast
10.18 Ewing Sarcoma - Patient Numbers & Forecast
10.19 Rhabdomyosarcoma - Patient Numbers & Forecast
10.2 Other Sarcoma, High Grade - Patient Numbers & Forecast
10.21 Other Sarcoma, Low Grade - Patient Numbers & Forecast
10.22 Teratoma - Patient Numbers & Forecast
10.23 Neuroblastoma - Patient Numbers & Forecast
10.24 Ganglioglioma - Patient Numbers & Forecast
10.25 Wilm’s Tumor - Patient Numbers & Forecast
10.26 Carcinoma (non-CPC) - Patient Numbers & Forecast
10.27 Lymphoma, Hodgkin’s - Patient Numbers & Forecast
10.28 Lymphoma, Non-hodgkin’s - Patient Numbers & Forecast
10.29 Leukemia - Patient Numbers & Forecast
10.3 Desmoid - Patient Numbers & Forecast
10.31 Melanoma - Patient Numbers & Forecast
10.32 Pineal Parenchymal Tumor - Patient Numbers & Forecast
10.33 Esthesioneuroblastoma - Patient Numbers & Forecast
10.34 Angiofibroma - Patient Numbers & Forecast
10.35 Extrarenal Rhabdoid Tumor - Patient Numbers & Forecast
10.36 Others - Patient Numbers & Forecast
11 EUROPE PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
11.1 Europe Pediatric Proton Therapy Market
11.2 Europe Pediatric Proton Therapy Potential Market
12 EUROPE PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)
12.1 Europe – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
12.2 Europe – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
13 EUROPE PEDIATRIC PROTON THERAPY MARKET SHARE BY COUNTRIES
14 FRANCE PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
14.1 France – Pediatric Proton Therapy Market & Forecast
14.2 France – Potential Pediatric Proton Therapy Market
15 FRANCE PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
15.1 France – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
15.2 France – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
16 GERMANY PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
16.1 Germany – Pediatric Proton Therapy Market & Forecast
16.2 Germany – Potential Pediatric Proton Therapy Market
17 GERMANY PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
17.1 Germany – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
17.2 Germany – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
18 SWITZERLAND PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
18.1 Switzerland Pediatric Proton Therapy Market & Forecast
18.2 Switzerland – Pediatric Proton Therapy Potential Market & Forecast
19 SWITZERLAND PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
19.1 Switzerland – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
19.2 Switzerland – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
20 SWEDEN PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
20.1 Sweden - Pediatric Proton Therapy Market & Forecast
20.2 Sweden – Potential Pediatric Proton Therapy Market & Forecast
21 SWEDEN PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
21.1 Sweden – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
21.2 Sweden – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
22 CZECH REPUBLIC PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
22.1 Czech Republic Pediatric Proton Therapy Market & Forecast
22.2 Czech Republic Potential Pediatric Proton Therapy Market & Forecast
23 CZECH REPUBLIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
23.1 Czech Republic – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
23.2 Czech Republic – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
24 UNITED KINGDOM PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
24.1 United Kingdom Pediatric Proton Therapy Market & Forecast
24.2 United Kingdom Pediatric Proton therapy Market with NHS Expenditure
24.3 United Kingdom Pediatric Proton Therapy Potential Market & Forecast
25 UNITED KINGDOM PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
25.1 United Kingdom – Patients Treated with Proton Therapy Numbers & Forecast
25.2 Treatment Patterns of Pediatric Patients with Proton Therapy in United Kingdom and Abroad
25.3 United Kingdom – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
26 ASIA PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
26.1 Asia Pediatric Proton Therapy Market & Forecast
26.2 Asia Pediatric Proton Therapy - Potential Market & Forecast
27 ASIA PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)
27.1 Asia – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
27.2 Asia – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
28 BY COUNTRIES – ASIA PEDIATRIC PROTON THERAPY MARKET SHARE
29 JAPAN PEDIATRIC PROTON THERAPY - ACTUAL & POTENTIAL MARKET
29.1 Japan – Pediatric Proton Therapy Market & Forecast
29.2 Japan – Potential Pediatric Proton Therapy Market & Forecast
30 JAPAN PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
30.1 Japan – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
30.2 Japan – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
31 CHINA PEDIATRIC PROTON THERAPY MARKET - ACTUAL & POTENTIAL MARKET
31.1 China – Pediatric Proton Therapy Market & Forecast
31.2 China – Potential Pediatric Proton Therapy Market
32 CHINA PEDIATRIC PROTON THERAPY PATIENTS NUMBER – ACTUAL AND POTENTIAL
32.1 China – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
32.2 China – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
33 SOUTH KOREA PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
33.1 South Korea – Pediatric Proton Therapy Market & Forecast
33.2 South Korea – Potential Pediatric Proton Therapy Market & Forecast
34 SOUTH KOREA PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
34.1 South Korea – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
34.2 South Korea – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
35 COMPONENTS OF A STANDARD PROTON THERAPY CENTER
35.1 Proton Accelerator
35.1.1 Synchrotrons (example: LLUMC at Loma Linda)
35.1.2 Cyclotrons (example: MGH Boston)
35.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
35.1.4 H-minus Synchrotrons
35.1.5 Separated Sector Cyclotrons
35.1.6 Super-conducting Cyclotrons
35.1.7 Fast Cycling Synchrotron
35.2 Beam Transport System
35.3 Beam Delivery System
35.3.1 The Passive Scattering Technique
35.3.2 Beam Scanning
35.4 Nozzle
35.4.1 Single Scattering
35.4.2 Double Scattering
35.4.3 Uniform Scanning Nozzle
35.4.4 Pencil Scanning Nozzle
35.5 Treatment Planning System
35.6 Image Viewers
35.7 Patient Positioning System (PPS)
35.8 Human Resource
36 PROTON THERAPY – DRIVING FACTORS
36.1 Technology Advancement
36.2 Rising Prevalence of Pediatric Cancer Globally
37 PROTON THERAPY – CHALLENGES
37.1 Requires Huge Investment
37.2 Operations Challenges
38 GLOBAL PROTON THERAPY - COMPANY ANALYSIS (2010-2021)
38.1 IBA Proton Therapy
38.1.1 Sales Analysis
38.1.2 IBA List of Proton Therapy Centers
38.2 Varian Medical Systems
38.2.1 Sales Analysis
38.3 Mitsubishi Electric Corporation
38.3.1 Sales Analysis
38.3.2 Mitsubishi List of Proton Therapy Center
38.4 Hitachi
38.4.1 Sales Analysis
38.4.2 Hitachi List of Proton Therapy Center
39 PROTON THERAPY – REIMBURSEMENT POLICIES
39.1 Proton Therapy Reimbursement Policies for Patients
39.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
2 GLOBAL PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)
2.1 Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
2.2 Pediatric Patients with Proton Therapy Potential Numbers & Forecast
3 GLOBAL PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
3.1 Pediatric Proton Therapy Market & Forecast
3.2 Pediatric Proton Therapy - Potential Market & Forecast
4 GLOBAL PEDIATRIC PROTON THERAPY MARKET SHARE & FORECAST
4.1 By Region (Asia, Europe, USA) – Global Pediatric Proton Therapy Market Share
4.2 By Countries – Global Pediatric Proton Therapy Market Share
5 UNITED STATES PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
5.1 United States Pediatric Proton Therapy Market & Forecast
5.2 United States Potential Pediatric Proton Therapy Market & Forecast
6 USA PEDIATRIC PROTON THERAPY MARKET BY AGE GROUP
6.1 By Age Group (<1) Year
6.2 By Age Group (1-4) Year
6.3 By Age Group (5-9) Year
6.4 By Age Group (10-14) Year
6.5 By Age Group (15-18) Year
7 USA PEDIATRIC PROTON THERAPY PATIENT NUMBER - ACTUAL AND POTENTIAL
7.1 USA Pediatric Patients Treated with Proton Therapy Numbers & Forecast
7.2 USA Pediatric Patients with Proton Therapy Potential Numbers & Forecast
8 USA PEDIATRIC PROTON THERAPY PATIENTS NUMBERS BY AGE GROUP
8.1 By Age (<1) Year
8.2 By Age (1- 4) Year
8.3 By Age (5- 9) Year
8.4 By Age (10-14) Year
8.5 By Age (15- 18) Year
9 TUMOR TYPES – USA PEDIATRICS PROTON THERAPY MARKET (2010 – 2021)
9.1 Glioma, Low Grade – Market & Forecast
9.2 Glioma, High Grade – Market & Forecast
9.3 Medulloblastoma – Market & Forecast
9.4 Ependymoma – Market & Forecast
9.5 ATRT – Market & Forecast
9.6 Germinoma, Pure – Market & Forecast
9.7 Germ Cell Tumor – Market & Forecast
9.8 Craniopharyngioma – Market & Forecast
9.9 PNET – Market & Forecast
9.1 Pineoblastoma – Market & Forecast
9.11 Chordoma/Chondrosarcoma – Market & Forecast
9.12 Meningioma – Market & Forecast
9.13 AVM – Market & Forecast
9.14 Adenoma – Market & Forecast
9.15 Choroid Plexus Carcinoma – Market & Forecast
9.16 Retinoblastoma – Market & Forecast
9.17 Osteosarcoma – Market & Forecast
9.18 Ewing Sarcoma – Market & Forecast
9.19 Rhabdomyosarcoma – Market & Forecast
9.2 Other Sarcoma, High Grade – Market & Forecast
9.21 Other Sarcoma, Low Grade – Market & Forecast
9.22 Teratoma – Market & Forecast
9.23 Neuroblastoma – Market & Forecast
9.24 Ganglioglioma – Market & Forecast
9.25 Wilm’s Tumor – Market & Forecast
9.26 Carcinoma (non-CPC) – Market & Forecast
9.27 Lymphoma, Hodgkin’s – Market & Forecast
9.28 Lymphoma, Non-hodgkin’s – Market & Forecast
9.29 Leukemia – Market & Forecast
9.3 Desmoid – Market & Forecast
9.31 Melanoma – Market & Forecast
9.32 Pineal Parenchymal Tumor – Market & Forecast
9.33 Esthesioneuroblastoma – Market & Forecast
9.34 Angiofibroma – Market & Forecast
9.35 Extrarenal Rhabdoid Tumor – Market & Forecast
9.36 Others – Market & Forecast
10 TUMOR TYPES USA PEDIATRICS PROTON THERAPY PATIENTS (2010 – 2021)
10.1 Glioma, Low Grade – Patient Numbers & Forecast
10.2 Glioma, High Grade - Patient Numbers & Forecast
10.3 Medulloblastoma - Patient Numbers & Forecast
10.4 Ependymoma - Patient Numbers & Forecast
10.5 ATRT - Patient Numbers & Forecast
10.6 Germinoma, pure - Patient Numbers & Forecast
10.7 Germ Cell Tumor - Patient Numbers & Forecast
10.8 Craniopharyngioma - Patient Numbers & Forecast
10.9 PNET - Patient Numbers & Forecast
10.1 Pineoblastoma - Patient Numbers & Forecast
10.11 Chordoma/Chondrosarcoma - Patient Numbers & Forecast
10.12 Meningioma - Patient Numbers & Forecast
10.13 AVM - Patient Numbers & Forecast
10.14 Adenoma - Patient Numbers & Forecast
10.15 Choroid Plexus Carcinoma - Patient Numbers & Forecast
10.16 Retinoblastoma - Patient Numbers & Forecast
10.17 Osteosarcoma - Patient Numbers & Forecast
10.18 Ewing Sarcoma - Patient Numbers & Forecast
10.19 Rhabdomyosarcoma - Patient Numbers & Forecast
10.2 Other Sarcoma, High Grade - Patient Numbers & Forecast
10.21 Other Sarcoma, Low Grade - Patient Numbers & Forecast
10.22 Teratoma - Patient Numbers & Forecast
10.23 Neuroblastoma - Patient Numbers & Forecast
10.24 Ganglioglioma - Patient Numbers & Forecast
10.25 Wilm’s Tumor - Patient Numbers & Forecast
10.26 Carcinoma (non-CPC) - Patient Numbers & Forecast
10.27 Lymphoma, Hodgkin’s - Patient Numbers & Forecast
10.28 Lymphoma, Non-hodgkin’s - Patient Numbers & Forecast
10.29 Leukemia - Patient Numbers & Forecast
10.3 Desmoid - Patient Numbers & Forecast
10.31 Melanoma - Patient Numbers & Forecast
10.32 Pineal Parenchymal Tumor - Patient Numbers & Forecast
10.33 Esthesioneuroblastoma - Patient Numbers & Forecast
10.34 Angiofibroma - Patient Numbers & Forecast
10.35 Extrarenal Rhabdoid Tumor - Patient Numbers & Forecast
10.36 Others - Patient Numbers & Forecast
11 EUROPE PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
11.1 Europe Pediatric Proton Therapy Market
11.2 Europe Pediatric Proton Therapy Potential Market
12 EUROPE PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)
12.1 Europe – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
12.2 Europe – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
13 EUROPE PEDIATRIC PROTON THERAPY MARKET SHARE BY COUNTRIES
14 FRANCE PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
14.1 France – Pediatric Proton Therapy Market & Forecast
14.2 France – Potential Pediatric Proton Therapy Market
15 FRANCE PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
15.1 France – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
15.2 France – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
16 GERMANY PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
16.1 Germany – Pediatric Proton Therapy Market & Forecast
16.2 Germany – Potential Pediatric Proton Therapy Market
17 GERMANY PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
17.1 Germany – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
17.2 Germany – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
18 SWITZERLAND PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
18.1 Switzerland Pediatric Proton Therapy Market & Forecast
18.2 Switzerland – Pediatric Proton Therapy Potential Market & Forecast
19 SWITZERLAND PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
19.1 Switzerland – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
19.2 Switzerland – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
20 SWEDEN PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
20.1 Sweden - Pediatric Proton Therapy Market & Forecast
20.2 Sweden – Potential Pediatric Proton Therapy Market & Forecast
21 SWEDEN PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
21.1 Sweden – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
21.2 Sweden – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
22 CZECH REPUBLIC PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
22.1 Czech Republic Pediatric Proton Therapy Market & Forecast
22.2 Czech Republic Potential Pediatric Proton Therapy Market & Forecast
23 CZECH REPUBLIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
23.1 Czech Republic – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
23.2 Czech Republic – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
24 UNITED KINGDOM PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
24.1 United Kingdom Pediatric Proton Therapy Market & Forecast
24.2 United Kingdom Pediatric Proton therapy Market with NHS Expenditure
24.3 United Kingdom Pediatric Proton Therapy Potential Market & Forecast
25 UNITED KINGDOM PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
25.1 United Kingdom – Patients Treated with Proton Therapy Numbers & Forecast
25.2 Treatment Patterns of Pediatric Patients with Proton Therapy in United Kingdom and Abroad
25.3 United Kingdom – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
26 ASIA PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)
26.1 Asia Pediatric Proton Therapy Market & Forecast
26.2 Asia Pediatric Proton Therapy - Potential Market & Forecast
27 ASIA PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)
27.1 Asia – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
27.2 Asia – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
28 BY COUNTRIES – ASIA PEDIATRIC PROTON THERAPY MARKET SHARE
29 JAPAN PEDIATRIC PROTON THERAPY - ACTUAL & POTENTIAL MARKET
29.1 Japan – Pediatric Proton Therapy Market & Forecast
29.2 Japan – Potential Pediatric Proton Therapy Market & Forecast
30 JAPAN PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
30.1 Japan – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
30.2 Japan – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
31 CHINA PEDIATRIC PROTON THERAPY MARKET - ACTUAL & POTENTIAL MARKET
31.1 China – Pediatric Proton Therapy Market & Forecast
31.2 China – Potential Pediatric Proton Therapy Market
32 CHINA PEDIATRIC PROTON THERAPY PATIENTS NUMBER – ACTUAL AND POTENTIAL
32.1 China – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
32.2 China – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
33 SOUTH KOREA PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET
33.1 South Korea – Pediatric Proton Therapy Market & Forecast
33.2 South Korea – Potential Pediatric Proton Therapy Market & Forecast
34 SOUTH KOREA PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL
34.1 South Korea – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
34.2 South Korea – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
35 COMPONENTS OF A STANDARD PROTON THERAPY CENTER
35.1 Proton Accelerator
35.1.1 Synchrotrons (example: LLUMC at Loma Linda)
35.1.2 Cyclotrons (example: MGH Boston)
35.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
35.1.4 H-minus Synchrotrons
35.1.5 Separated Sector Cyclotrons
35.1.6 Super-conducting Cyclotrons
35.1.7 Fast Cycling Synchrotron
35.2 Beam Transport System
35.3 Beam Delivery System
35.3.1 The Passive Scattering Technique
35.3.2 Beam Scanning
35.4 Nozzle
35.4.1 Single Scattering
35.4.2 Double Scattering
35.4.3 Uniform Scanning Nozzle
35.4.4 Pencil Scanning Nozzle
35.5 Treatment Planning System
35.6 Image Viewers
35.7 Patient Positioning System (PPS)
35.8 Human Resource
36 PROTON THERAPY – DRIVING FACTORS
36.1 Technology Advancement
36.2 Rising Prevalence of Pediatric Cancer Globally
37 PROTON THERAPY – CHALLENGES
37.1 Requires Huge Investment
37.2 Operations Challenges
38 GLOBAL PROTON THERAPY - COMPANY ANALYSIS (2010-2021)
38.1 IBA Proton Therapy
38.1.1 Sales Analysis
38.1.2 IBA List of Proton Therapy Centers
38.2 Varian Medical Systems
38.2.1 Sales Analysis
38.3 Mitsubishi Electric Corporation
38.3.1 Sales Analysis
38.3.2 Mitsubishi List of Proton Therapy Center
38.4 Hitachi
38.4.1 Sales Analysis
38.4.2 Hitachi List of Proton Therapy Center
39 PROTON THERAPY – REIMBURSEMENT POLICIES
39.1 Proton Therapy Reimbursement Policies for Patients
39.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
